The effect of 0.3 mg sublingual nitroglycerin (NTG) was evaluated by hemodynamic measurements and precordial S-T-segment mapping in 17 patients following acute myocardial infarction.
SUMMARY
The effect of 0.3 mg sublingual nitroglycerin (NTG) was evaluated by hemodynamic measurements and precordial S-T-segment mapping in 17 patients following acute myocardial infarction.
In all cases NTG produced a prompt reduction in mean pulmonary capillary wedge pressure (PCW) Pulmonary artery (PA) and PCW pressures were monitored by the Swan-Ganz flow-directed catheter, and arterial pressures through an indwelling radial artery cannula. Cardiac output (CO) measurements were made at least in duplicate by the dye-dilution technic with 1-ml injections (7 mg) of indocyanine green dye into the pulmonary artery followed by 5 ml saline flush. Sampling was carried out through a Gilford densitometer from the radial artery with a Harvard constant-speed withdrawal pump (30 ml/ min). Blood was reinfused into the artery after each output measurement. Dye curves were recorded directly and the output signal was passed to a Lexington analog computer. Outputs were accepted if the integration curve held constant during exponential decay for 3 points separated by 0.5-sec intervals. The computer was calibrated with a 1:1000 dilution of dye in blood, prepared with a Hamilton micropipette.
Nine patients in groups I and II underwent precordial electrocardiography using a 35-electrode blanket, recently described by Maroko et al.
-) The sum of the S-T-segment elevations and the number of sites in which S-T-segment elevations exceeded 0.1 mv were analyzed independently by two observers.
During the 10-min control period heart rate, mean arterial pressure (MAP), PA, PCW pressure, and CO were recorded together with the precordial S-T-segment map. After completion of control measurements, 0.3 mg nitroglycerin was administered sublingually. MAP and PCW pressures were then continuously monitored and the initial measurements were repeated at peak nitroglycerin effect (5-10 min after the dose). A third set of measurements was taken at 60 min when pressures had retumed to control levels.
Total peripheral resistance (TPR) in units was calculated by the formula: MAP/Cl. The left ventricular stroke-work index (LVSWI) in g-M/M2 was calculated by the formula: LVSWI= SI X (MAP-PCW) x 13.6/1000 where SIstroke index in ml/m2. The sum of S-T-segment elevations in 35 leads (EST) was used as an index of tissue injury, and the number of sites of S-T-segment elevation exceeding 0.1 mv (N-ST) was taken to reflect the extent of myocardial ischemic injury.
Student's t test for paired and unpaired data was used for all statistical calculations where applicable.
Results
At the time of study, all cases in group II had clinical evidence of left ventricular failure with rales and radiographic signs of pulmonary congestion. However, none was dyspneic and none noted subjective improvement. Two patients in group II were given nitroglycerin during persistent pain (table 1, A.I. and M.G.). Both stated that the pain diminished. The S-T-segment map in one (A.I. ) showed a definite decrease in both N-ST and EST.
All patients in group III had clinical and Xray evidence of pulmonary edema. All experienced improvement in their dyspnea. One, whose pulmonary edema had been present for 2 weeks on an intensive medical program, showed dramatic changes ( fig. 1) . When the series was considered as a whole, there was a significant fall in the PCW (19-14 mm Hg, P < 0.01) and a small but significant fall in MAP (85-82 mm Hg, P < 0.05). There was no significant change in HR, CI, or TPR.
The average values for the entire series obscure significant differences between groups. These differences are not apparent in PCW pressure, which fell 5 mm in group I, 4 mm in group II, and 6 mm in group III ( fig.  2) . Similarly, MAP response was uniform, falling 3 mm in group I, 3 mm in group II, and 4 mm in group III ( fig. 3) . CO, however, increased significantly in patients with elevated PCW, averaging 13% in group II (P < 0.01 and 25% in group III (P < 0.05). By contrast, group I patients with normal filling pressures showed a decreased CO of 9% (fig.  4) All nine patients who underwent precordial S-T mapping showed persistent S-T-segment elevation (1-3 days after infarction). Only onê Effect of NTG on cardiac output. CO increased significantly in patients with elevated PCW, averaging 13% in GROUP II and 25% in GROUP III. Inl patients wnith n.ormal PCW, CO decreased 9%.
had persistent pain. Nitroglycerin produced no significant change in seven, and a minimal change in one ( fig. 6, A) . The only case that showed obvious S-T-segment improvement was the patient with persistent pain ( fig. 6,   B ).
Discussion
Previous investigations in patients6, 11 have shown that nitroglycerin lowers systemic arterial pressure and left ventricular filling pressure, and our findings in patients with myocardial infarction are in agreement with this observation. There is considerable dispute, however, concerning the effects of this drug on cardiac ouptut which has been reported to rise, remain unchanged, or slightly decline. While these results are not entirely explained, the differences may be related to 
